IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Public ClinicalTrials.gov record NCT00663234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Study identification
- NCT ID
- NCT00663234
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- Network
- Enrollment
- 28 participants
Conditions and interventions
Conditions
Interventions
- Atorvastatin Drug
Drug
Eligibility (public fields only)
- Age range
- 10 Years to 23 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2009
- Primary completion
- Nov 30, 2014
- Completion
- Nov 30, 2014
- Last update posted
- Apr 5, 2016
2009 – 2014
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ. of Colorado Denver NICHD CRS (5052) | Aurora | Colorado | 80045 | — |
| Univ. of Miami Ped. Perinatal HIV/AIDS CRS (4201) | Miami | Florida | 33136 | — |
| University of South Florida Tampa (5018) | Tampa | Florida | 33620 | — |
| Chicago Children's CRS (4001) | Chicago | Illinois | 60614 | — |
| Tulane University (5095) | New Orleans | Louisiana | 70112 | — |
| Boston Medical Center Ped. HIV Program NICHD CRS (5011) | Boston | Massachusetts | 02118 | — |
| New York University NY (5012) | New York | New York | 10016 | — |
| Metropolitan Hospital (5003) | New York | New York | 10029 | — |
| Bronx-Lebanon Hospital IMPAACT CRS (6901) | The Bronx | New York | 10457 | — |
| St. Jude/UTHSC CRS (6501) | Memphis | Tennessee | 38105 | — |
| Texas Children's Hosp. CRS (3801) | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00663234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00663234 live on ClinicalTrials.gov.